|Product Overview :
||Recombinant Human KLK13 mature form (NP_056411.1) (Met 1-Ile 262), fused with The mature form of human KLK13 (NP_056411.1) (Met 1-Ile 262) was obtained after cleavage of the C-terminal human IgG1 Fc region from the purified chimera., was produced in Human
||Lyophilized from sterile filtered solution of 100mM Glycine, 10mM NaCl, 50mM Tris, pH 7.5
|Molecular Mass :
||The recombinant human KLK13 consists of 251 amino acids and predicts a molecular mass of 27.6 kDa. As a result of glycosylation, rhKLK13 migrates as an approximately 37 kDa band in SDS-PAGE.
||< 1.0 eu per μg of the protein as determined by the LAL method.
||Samples are stable for up to twelve months from date of receipt at -70oC.
||Store it under sterile conditions at -20oC~-70oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
||It is recommended that sterile water be added to the vial to prepare a stock solution. Centrifuge the vial at 4oC before opening to recover the entire contents.